In the late stage cohort, DDX21 expression showed no significant association with any of the examined clinicopathological features, including patient gender or age, tumor differentiation or stage, mucinous histology, tumor location, or mismatch repair status (Table 2). The gene discussed is DDX21; the disease is neoplasm.